NEW COMPOUNDS
    10.
    发明申请
    NEW COMPOUNDS 审中-公开
    新化合物

    公开(公告)号:US20110184014A1

    公开(公告)日:2011-07-28

    申请号:US12158589

    申请日:2006-12-19

    CPC分类号: C07D495/04

    摘要: The present invention relates to new mGluR1 and mGluR5 receptor subtype preferring ligands of formula (I); wherein Y represents a substituent selected from hydrogen, methyl, fluoro, chloro, bromo, methoxy; Z is hydrogen or methyl; R is an optionally substituted heteroaryl, and/or salts and/or hydrates and/or solvates thereof, to the processes for producing the same, to pharmaceutical compositions containing the same and to their use in therapy and/or prevention of pathological conditions which require the modulation of mGluR1 and mGluR5 receptors such as neurological disorders, psychiatric disorders, acute and chronic pain and neuromuscular dysfunctions of the lower urinary tract.

    摘要翻译: 本发明涉及新的mGluR1和mGluR5受体亚型优选式(I)的配体; 其中Y表示选自氢,甲基,氟,氯,溴,甲氧基的取代基; Z是氢或甲基; R是任选取代的杂芳基,和/或其盐和/或其水合物和/或溶剂合物,其制备方法,含有其的药物组合物及其在治疗和/或预防需要的病理状况中的用途 mGluR1和mGluR5受体的调节,如神经系统疾病,精神疾病,急性和慢性疼痛以及下泌尿道的神经肌肉功能障碍。